← boothcheck

AFL vs OSCR stock comparison

AFLAC INC vs Oscar Health, Inc., two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Neither company's growth is printed here, so the artifacts speak: Oscar Health's 28.5% free-cash yield is float, premiums collected ahead of claims, not profit, and its net margin sits at negative 0.3%; Aflac's 4.8% free-cash yield is the ordinary kind, backed by a 25.6% net margin. No multiple exists for Oscar this year; Aflac trades at 13.7 times earnings with a 2% dividend. The bet on Oscar is that technology-led individual-market insurance eventually earns like insurance; the bet on Aflac is that supplemental policies keep earning exactly as they have. One price contains a business model still being proven, the other a habit seven decades old.

Comparison updated 2026-07-10.

AFL vs OSCR: the numbers

MetricAFLOSCR
Price$120.07$29.79
Market cap$61.8B$9.8B
SectorManaged CareManaged Care
StageMatureGrowth
P/E13.7
P/B2.065.89
P/S3.410.74
EV/EBITDA309.2
Revenue growth+14.9%+30.5%
Operating margin15.2%
Net margin25.6%-0.3%
Return on equity15.5%-2.4%
Return on assets4.0%-0.4%
Return on invested capital0.5%
FCF yield4.8%28.5%
Dividend yield2.0%
Debt / equity0.260.26
Current ratio1.09
Altman Z (solvency)1.262.14
Piotroski F (quality)7 / 98 / 9
Full AFL report → Full OSCR report →
Get boothcheck's read on AFL and OSCR, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.